Covered recipient · General Payments record
DUNCAN M FAGUNDUS
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$5,812.67
- Reported across 478 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $217.62 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $78.52 | 3 |
| GlaxoSmithKline, LLC. | $60.23 | 4 |
| Amgen Inc. | $32.58 | 2 |
| Janssen Biotech, Inc. | $16.94 | 1 |
| Fresenius Kabi USA, LLC | $15.04 | 1 |
| Masimo Corporation | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.08 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103705613 | CMS |
| ABBVIE INC. | $27.90 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103705615 | CMS |
| ABBVIE INC. | $18.54 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103705617 | CMS |
| Amgen Inc. | $15.08 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111571978 | CMS |
| Amgen Inc. | $17.50 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111571976 | CMS |
| Fresenius Kabi USA, LLC | $15.04 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146945479 | CMS |
| GlaxoSmithKline, LLC. | $16.35 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115748225 | CMS |
| GlaxoSmithKline, LLC. | $16.20 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116535570 | CMS |
| GlaxoSmithKline, LLC. | $14.46 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116089846 | CMS |
| GlaxoSmithKline, LLC. | $13.22 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115878485 | CMS |
| Janssen Biotech, Inc. | $16.94 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078832582 | CMS |
| Masimo Corporation | $14.31 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152315908 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.